NCT06763965 2026-03-23Evaluating the Safety and Efficacy of BioTTT001 in Patients With Recurrent/Progressive High-grade Glioma.Beijing Bio-Targeting Therapeutics Technology Co., LtdPhase 1/2 Enrolling by invitation30 enrolled